These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Single daily doses of neuroleptic drugs. Brophy JJ Dis Nerv Syst; 1969 Feb; 30(2):120-3. PubMed ID: 5774571 [No Abstract] [Full Text] [Related]
5. [On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia]. Zolotnitskii RI; Kutsenok BM; Gastev MD Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(5):750-4. PubMed ID: 5363890 [No Abstract] [Full Text] [Related]
6. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [TBL] [Abstract][Full Text] [Related]
7. [Selection and dosages of therapeutic agents for the early stage of schizophrenia]. Yagi G; Watanabe E; Takano H Seishin Shinkeigaku Zasshi; 1999; 101(11):908-15. PubMed ID: 10756682 [No Abstract] [Full Text] [Related]
8. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol. Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652 [TBL] [Abstract][Full Text] [Related]
9. [The properdin system in patients with schizophrenia during the process of active therapy]. Kaz'mina SA Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):101-5. PubMed ID: 4147791 [No Abstract] [Full Text] [Related]
10. Effect of d-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol. Almirall M; Montaña J; Escribano E; Obach R; Berrozpe JD Arzneimittelforschung; 1996 Jul; 46(7):676-80. PubMed ID: 8842336 [TBL] [Abstract][Full Text] [Related]
12. Management of delirium associated with use of the intra-aortic balloon pump. Sanders KM; Stern TA Am J Crit Care; 1993 Sep; 2(5):371-7. PubMed ID: 8220668 [TBL] [Abstract][Full Text] [Related]
13. [Neuroleptic large dose therapy of schizophrenias]. Ungvári G; Pethö B Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506 [TBL] [Abstract][Full Text] [Related]
14. [Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia]. Mosketi KV; Mokhovikov AN; Aksent'ev SB; Goĭkhberg IG; Kryzhanovskiĭ GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):589-96. PubMed ID: 6730829 [TBL] [Abstract][Full Text] [Related]
15. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Roose K Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558 [TBL] [Abstract][Full Text] [Related]
16. On the trail of a cognitive enhancer for the treatment of schizophrenia. Stip E; Chouinard S; Boulay LJ Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228 [TBL] [Abstract][Full Text] [Related]
17. Medicine. What are the right targets for psychopharmacology? Hyman SE; Fenton WS Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001 [No Abstract] [Full Text] [Related]
18. Treatment of patients with delirium. Tauscher J; Tauscher-Wisniewski S; Kasper S Am J Psychiatry; 2000 Oct; 157(10):1711. PubMed ID: 11007745 [No Abstract] [Full Text] [Related]
19. [Controlled study of insulin treatment, insulin treatment with chlorpromazine and chlorpromazine alone of schizophrenics]. Zhang XP Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):334-6. PubMed ID: 3447840 [No Abstract] [Full Text] [Related]
20. [Predicting the effect of psychopharmacotherapy in schizophrenic patients]. Dikiĭ NT Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]